ProFound Therapeutics Gains Up to $35M From Gates Foundation for Preeclampsia Discovery

Company: ProFound Therapeutics · Funder: Gates Foundation · Commitment: Up to $35M · Focus: Preeclampsia and Eclampsia · Date: August 27, 2026 Summary ProFound Therapeutics received a Gates Foundation funding commitment of up to $35 million, including $20 million initially, to identify biomarkers, drug targets…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *